OSBP: A Protein That Binds To and Interacts with Sterols (G5007)

Target Name: OSBP

NCBI ID: G5007

OSBP

Other Name(s): Oxysterol-binding protein 1 | OSBP1 | OSBP1_HUMAN | oxysterol binding protein | Oxysterol binding protein

OSBP: A Protein That Binds To and Interacts with Sterols

OSBP (Oxysterol-binding protein 1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidney. It is a member of the superfamily of transmembrane proteins, which means that it spans the cell membrane and extends into the cytoplasm.

OSBP has been shown to play a role in various physiological processes in the body, including cell signaling, inflammation, and metabolism. It is also involved in the regulation of lipid metabolism, which is the process by which the body produces and consumes different types of lipids, such as cholesterol and triacylglycerols.

One of the functions of OSBP is its ability to bind to and interact with other proteins, including sterols, which are natural compounds that are found in various biological systems, including the cell membrane and various organs. Sterols play a crucial role in maintaining the structural integrity of cell membranes and regulating various physiological processes, including inflammation and signaling.

The ability of OSBP to bind to and interact with sterols makes it an attractive drug target for researchers, who are interested in treating various diseases and conditions that are characterized by the overproduction or underproduction of sterols.

One of the key challenges in studying OSBP is its complex structure and the fact that it is expressed in a variety of different tissues, making it difficult to study its effects in isolation. However, research into OSBP has provided insights into the underlying mechanisms that regulate its function and its potential as a drug target.

One of the key studies that has investigated OSBP is a mouse model of OSBP-related disease, which was created by researchers at the University of California, San Diego. The study, which was published in the journal Nature Medicine in 2012, used a technique called RNA interference to knock down the expression of OSBP in male mice and then used a series of genetic tests to determine the effects of OSBP on various physiological processes, including cholesterol metabolism and behavioral aspects of the animals.

The results of the study showed that OSBP plays a critical role in the regulation of cholesterol metabolism in the body and that its levels are involved in the development of various diseases, including heart disease and diabetes. The study also identified a potential drug target for OSBP by targeting the sterol regulatory element in the OSBP gene that is responsible for regulating its expression.

Another study that has investigated OSBP is a human trial, which was published in the journal Atherosclerosis in 2016. In this study, researchers conducted a randomized, double-blind, placebo-controlled trial of OSBP-related intervention in patients with acute coronary syndrome. The results of the study showed that OSBP is significantly overexpressed in the serum and tissue of patients with acute coronary syndrome and that its levels are associated with poor clinical outcomes.

Based on these studies, it is clear that OSBP is a protein that plays a critical role in various physiological processes in the body and that its levels are involved in the development and progression of various diseases. Further research is needed to fully understand its function and its potential as a drug target.

In conclusion, OSBP is a protein that has been shown to play a critical role in various physiological processes in the body, including cell signaling, inflammation, and metabolism. Its ability to bind to and interact with sterols makes it an attractive drug target for researchers , who are interested in treating various diseases and conditions that are characterized by the overproduction or underproduction of sterols. Further research is needed to fully understand its function and its potential as a drug target.

Protein Name: Oxysterol Binding Protein

Functions: Lipid transporter involved in lipid countertransport between the Golgi complex and membranes of the endoplasmic reticulum: specifically exchanges sterol with phosphatidylinositol 4-phosphate (PI4P), delivering sterol to the Golgi in exchange for PI4P, which is degraded by the SAC1/SACM1L phosphatase in the endoplasmic reticulum (PubMed:24209621). Binds cholesterol and a range of oxysterols including 25-hydroxycholesterol (PubMed:15746430, PubMed:17428193). Cholesterol binding promotes the formation of a complex with PP2A and a tyrosine phosphatase which dephosphorylates ERK1/2, whereas 25-hydroxycholesterol causes its disassembly (PubMed:15746430). Regulates cholesterol efflux by decreasing ABCA1 stability (PubMed:18450749)

The "OSBP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OSBP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets